JPY 227.0
(-0.44%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 1.36 Billion JPY | -64.65% |
2022 | 3.86 Billion JPY | -3.81% |
2021 | 4.01 Billion JPY | 9.02% |
2020 | 3.68 Billion JPY | 263.94% |
2019 | 1.01 Billion JPY | 5.47% |
2018 | 960.51 Million JPY | -20.91% |
2017 | 1.21 Billion JPY | -16.19% |
2016 | 1.44 Billion JPY | 1.21% |
2015 | 1.43 Billion JPY | -8.67% |
2014 | 1.56 Billion JPY | 24.18% |
2013 | 1.26 Billion JPY | -25.58% |
2012 | 1.69 Billion JPY | 10.2% |
2011 | 1.53 Billion JPY | 21.63% |
2010 | 1.26 Billion JPY | 3.59% |
2009 | 1.22 Billion JPY | 14.34% |
2008 | 1.06 Billion JPY | -13.95% |
2007 | 1.24 Billion JPY | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 FY | 1.36 Billion JPY | -64.65% |
2023 Q4 | 1.36 Billion JPY | -5.02% |
2023 Q3 | 1.43 Billion JPY | -59.96% |
2023 Q2 | 3.59 Billion JPY | -3.74% |
2023 Q1 | 3.73 Billion JPY | -3.46% |
2022 Q1 | 4.12 Billion JPY | 2.68% |
2022 FY | 3.86 Billion JPY | -3.81% |
2022 Q4 | 3.86 Billion JPY | -3.75% |
2022 Q3 | 4.01 Billion JPY | -0.57% |
2022 Q2 | 4.03 Billion JPY | -2.12% |
2021 FY | 4.01 Billion JPY | 9.02% |
2021 Q1 | 3.33 Billion JPY | -9.65% |
2021 Q4 | 4.01 Billion JPY | 40.51% |
2021 Q3 | 2.86 Billion JPY | -1.46% |
2021 Q2 | 2.9 Billion JPY | -12.85% |
2020 Q1 | 1.11 Billion JPY | 9.6% |
2020 Q2 | 1.56 Billion JPY | 40.72% |
2020 Q4 | 3.68 Billion JPY | 67.97% |
2020 FY | 3.68 Billion JPY | 263.94% |
2020 Q3 | 2.19 Billion JPY | 40.48% |
2019 FY | 1.01 Billion JPY | 5.47% |
2019 Q1 | 850.31 Million JPY | -11.47% |
2019 Q2 | 986.87 Million JPY | 16.06% |
2019 Q3 | 895.74 Million JPY | -9.23% |
2019 Q4 | 1.01 Billion JPY | 13.09% |
2018 Q2 | 1.03 Billion JPY | -7.81% |
2018 Q4 | 960.51 Million JPY | -9.09% |
2018 FY | 960.51 Million JPY | -20.91% |
2018 Q1 | 1.12 Billion JPY | -7.63% |
2018 Q3 | 1.05 Billion JPY | 2.16% |
2017 Q4 | 1.21 Billion JPY | -7.09% |
2017 FY | 1.21 Billion JPY | -16.19% |
2017 Q3 | 1.3 Billion JPY | -6.62% |
2017 Q2 | 1.39 Billion JPY | -6.1% |
2017 Q1 | 1.49 Billion JPY | 2.87% |
2016 Q4 | 1.44 Billion JPY | -5.91% |
2016 Q3 | 1.54 Billion JPY | -1.61% |
2016 Q1 | 1.32 Billion JPY | -7.16% |
2016 Q2 | 1.56 Billion JPY | 17.76% |
2016 FY | 1.44 Billion JPY | 1.21% |
2015 Q2 | 1.54 Billion JPY | 7.68% |
2015 Q1 | 1.43 Billion JPY | -8.37% |
2015 Q4 | 1.43 Billion JPY | 0.06% |
2015 Q3 | 1.43 Billion JPY | -7.49% |
2015 FY | 1.43 Billion JPY | -8.67% |
2014 Q2 | 1.39 Billion JPY | -0.66% |
2014 FY | 1.56 Billion JPY | 24.18% |
2014 Q4 | 1.56 Billion JPY | -2.34% |
2014 Q3 | 1.6 Billion JPY | 15.46% |
2014 Q1 | 1.39 Billion JPY | 10.86% |
2013 Q2 | 1.41 Billion JPY | -6.97% |
2013 Q3 | 1.42 Billion JPY | 0.65% |
2013 Q4 | 1.26 Billion JPY | -11.4% |
2013 Q1 | 1.52 Billion JPY | -10.29% |
2013 FY | 1.26 Billion JPY | -25.58% |
2012 Q1 | 1.72 Billion JPY | 12.38% |
2012 Q3 | 1.73 Billion JPY | -7.36% |
2012 Q4 | 1.69 Billion JPY | -1.95% |
2012 FY | 1.69 Billion JPY | 10.2% |
2012 Q2 | 1.86 Billion JPY | 7.95% |
2011 Q4 | 1.53 Billion JPY | 7.16% |
2011 FY | 1.53 Billion JPY | 21.63% |
2011 Q3 | 1.43 Billion JPY | 0.43% |
2011 Q2 | 1.43 Billion JPY | -10.6% |
2011 Q1 | 1.59 Billion JPY | 26.43% |
2010 Q1 | 1.39 Billion JPY | 13.95% |
2010 FY | 1.26 Billion JPY | 3.59% |
2010 Q3 | 1.59 Billion JPY | 30.11% |
2010 Q4 | 1.26 Billion JPY | -20.54% |
2010 Q2 | 1.22 Billion JPY | -12.06% |
2009 Q4 | 1.22 Billion JPY | -35.61% |
2009 Q3 | 1.89 Billion JPY | 56.1% |
2009 Q2 | 1.21 Billion JPY | 11.95% |
2009 Q1 | 1.08 Billion JPY | 1.62% |
2009 FY | 1.22 Billion JPY | 14.34% |
2008 Q4 | 1.06 Billion JPY | -7.3% |
2008 Q3 | 1.15 Billion JPY | 5.69% |
2008 Q2 | 1.09 Billion JPY | 0.0% |
2008 FY | 1.06 Billion JPY | -13.95% |
2007 FY | 1.24 Billion JPY | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Shin Nippon Biomedical Laboratories, Ltd. | 26.33 Billion JPY | 94.81% |
DNA Chip Research Inc. | - JPY | -Infinity% |
Cosmo Bio Company,Limited | 20 Million JPY | -6733.165% |
H.U. Group Holdings, Inc. | 81.94 Billion JPY | 98.332% |
FALCO HOLDINGS Co., Ltd. | 817 Million JPY | -67.275% |
BML, Inc. | 5.26 Billion JPY | 74.043% |
Human Metabolome Technologies, Inc. | 226.3 Million JPY | -503.895% |